Berolina innovative Research and Development Services Pharma GmbH (BiRDS Pharma GmbH), a company integrated into the network of the BDD/CDRD Group pursues own drug development projects based on IP generated within the Group.

Based on the expertise and know how of the Group as well as on proprietary process and technology platforms, BiRDS Pharma GmbH manages drug development projects in all phases from early stage to compilation of Dossier for submission as well as a variety of creative solutions for portfolio management and development of premium drugs.

BiRDS Pharma GmbH is focussing on the development of the most promising drug candidates form the group’s project pipeline based on Atomic Substitution Technology (AST). The projects are taken at fast track to a development stage that allows for partnering with the pharmaceutical industry.